Antivirals: Difference between revisions
(Text replacement - "OR" to "'''OR'''") |
No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 16: | Line 16: | ||
*[[Peramivir]] | *[[Peramivir]] | ||
*[[Zanamivir]] | *[[Zanamivir]] | ||
===Endonuclease Inhibitors=== | |||
*[[Baloxavir marboxil]] | |||
==Interferons== | ==Interferons== | ||
| Line 25: | Line 28: | ||
**[[Emtricitabine/tenofovir]] (Truvada) + raltegravir | **[[Emtricitabine/tenofovir]] (Truvada) + raltegravir | ||
**[[Emtricitabine/tenofovir]] + dolutegravir | **[[Emtricitabine/tenofovir]] + dolutegravir | ||
**Abacavir/lamivudine (Epzicom) + dolutegravir '''OR''' abacavir/lamivudine/dolutegravir (Triumeq) | **[[Abacavir/lamivudine]] (Epzicom) + dolutegravir '''OR''' [[abacavir/lamivudine]]/dolutegravir (Triumeq) | ||
**[[Emtricitabine/tenofovir]]/elvitegravir/cobicistat (Stribild) | **[[Emtricitabine/tenofovir]]/elvitegravir/cobicistat (Stribild) | ||
**[[Emtricitabine/tenofovir]] + ritonavir + darunavir | **[[Emtricitabine/tenofovir]] + ritonavir + darunavir | ||
| Line 42: | Line 45: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] [[Category:ID]] | ||
Latest revision as of 14:52, 18 March 2020
Anti-herpetic agents
Anti-influenza agents
Adamantane Derivatives
Neuraminidase Inhibitors
Endonuclease Inhibitors
Interferons
HAART
- HIV regimen that typically consists of combination of 2 nucleoside and/or non-nucleoside reverse transcriptase inhibitors PLUS a protease inhibitor, reverse-transcriptase inhibitor, or integrase inhibitor
- US DHHS first-line regimens
- Emtricitabine/tenofovir (Truvada) + raltegravir
- Emtricitabine/tenofovir + dolutegravir
- Abacavir/lamivudine (Epzicom) + dolutegravir OR abacavir/lamivudine/dolutegravir (Triumeq)
- Emtricitabine/tenofovir/elvitegravir/cobicistat (Stribild)
- Emtricitabine/tenofovir + ritonavir + darunavir
- WHO first-line regimen
- Emtricitabine/tenofovir/efavirenz (Atripla)
- Tenofovir + lamivudine + efavirenz